In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 219823-47-9, name is (R)-Tetrahydrofuran-3-yl 4-methylbenzenesulfonate, introducing its new discovery. category: Tetrahydrofurans
The invention relates to quinoline or quinazoline derivatives, its preparation process and its application in medicine. Specifically, the invention relates to a kind of formula (I) of the quinoline or quinazoline derivatives and their pharmaceutically acceptable salt or pharmaceutical composition containing the same, and its preparation method, the invention further relates to the quinoline or quinazoline derivatives and their pharmaceutically acceptable salt or pharmaceutical composition containing the same in the preparation of therapeutic agents, in particular the use of protein kinase inhibitor, wherein the general formula (I) of the substituent is the same as defined in the specification. (by machine translation)
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 219823-47-9, and how the biochemistry of the body works.Formula: C11H14O4S
Reference：
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem